Verdiva Bio raised $410m in Series A funding co-led by Forbion and General Atlantic

Biotech Health services Manufacturing Pharma

United Kingdom

Netherlands

United States

Singapore

China

Investments

10 December 2024

Share:

Verdiva Bio (company)

United Kingdom

Biotech Health services Manufacturing Pharma

Total investments received (USD): 410m

Round value (USD): 410m

Round investors: Forbion Capital Partners General Atlantic OrbiMed Advisors RA Capital Management Logos Capital Lyfe Capital Lilly Asia Ventures

Company: Verdiva Bio

Industry: Biotech Health services Manufacturing Pharma

Related deals

Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.

Biotech Health services Manufacturing

United Kingdom

France

Israel

United States

Investments 07 June 2025

CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.

Biotech Health services Manufacturing

United Kingdom

Netherlands

United States

Investments 09 May 2025

Isomorphic Labs raised $600m led by Thrive Capital, with participation from Google Ventures.

AI (big data) Health services Pharma Software Services

United Kingdom

United States

Investments 19 March 2025

OrganOx completed a $142 million primary and secondary equity financing led by HealthQuest Capital, joined by BGF and Lauxera Capital Partners

Health services Manufacturing

United Kingdom

France

Belgium

United States

Investments 14 February 2025

Purespring Therapeutics raised £80M series B led by Sofinnova Partners, joined by British Patient Capital, Syncona, Gilde Healthcare and Forbion.

Biotech Health services

United Kingdom

Netherlands

France

Investments 02 October 2024